BlackRock Inc. increased its position in shares of Owens & Minor, Inc. (NYSE:OMI) by 8,301.0% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 7,423,066 shares of the company’s stock after buying an additional 7,334,707 shares during the period. BlackRock Inc. owned about 12.16% of Owens & Minor worth $256,840,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also made changes to their positions in OMI. Dimensional Fund Advisors LP increased its position in Owens & Minor by 8.6% in the first quarter. Dimensional Fund Advisors LP now owns 2,567,308 shares of the company’s stock valued at $88,828,000 after buying an additional 202,892 shares in the last quarter. JPMorgan Chase & Co. boosted its stake in shares of Owens & Minor by 136.5% in the first quarter. JPMorgan Chase & Co. now owns 1,609,977 shares of the company’s stock valued at $55,705,000 after buying an additional 929,196 shares during the last quarter. Pzena Investment Management LLC boosted its stake in shares of Owens & Minor by 18.8% in the first quarter. Pzena Investment Management LLC now owns 1,579,596 shares of the company’s stock valued at $54,654,000 after buying an additional 250,263 shares during the last quarter. Macquarie Group Ltd. boosted its stake in Owens & Minor by 4.3% in the fourth quarter. Macquarie Group Ltd. now owns 1,243,265 shares of the company’s stock worth $43,875,000 after buying an additional 50,862 shares in the last quarter. Finally, Bank of New York Mellon Corp boosted its stake in Owens & Minor by 4.1% in the first quarter. Bank of New York Mellon Corp now owns 1,091,839 shares of the company’s stock worth $37,779,000 after buying an additional 43,445 shares in the last quarter. 98.35% of the stock is currently owned by institutional investors and hedge funds.
Owens & Minor, Inc. (NYSE:OMI) traded down 0.50% on Friday, reaching $31.85. 427,920 shares of the company’s stock traded hands. Owens & Minor, Inc. has a 52-week low of $30.43 and a 52-week high of $37.02. The company’s 50 day moving average is $31.95 and its 200-day moving average is $34.02. The stock has a market cap of $1.95 billion, a price-to-earnings ratio of 18.94 and a beta of 1.01.
Owens & Minor (NYSE:OMI) last announced its quarterly earnings results on Tuesday, May 2nd. The company reported $0.41 EPS for the quarter, missing analysts’ consensus estimates of $0.42 by $0.01. Owens & Minor had a return on equity of 12.28% and a net margin of 1.08%. The company had revenue of $2.33 billion during the quarter. Equities analysts expect that Owens & Minor, Inc. will post $1.78 EPS for the current year.
The firm also recently disclosed a quarterly dividend, which was paid on Friday, June 30th. Investors of record on Thursday, June 15th were issued a $0.2575 dividend. This represents a $1.03 dividend on an annualized basis and a dividend yield of 3.23%. The ex-dividend date was Tuesday, June 13th. Owens & Minor’s payout ratio is 60.95%.
A number of research firms have issued reports on OMI. Jefferies Group LLC reiterated a “hold” rating and set a $36.00 target price on shares of Owens & Minor in a report on Friday, April 21st. Zacks Investment Research downgraded shares of Owens & Minor from a “hold” rating to a “sell” rating in a research note on Friday, May 5th. TheStreet downgraded shares of Owens & Minor from a “b” rating to a “c+” rating in a research note on Thursday, May 4th. Finally, BidaskClub upgraded shares of Owens & Minor from a “sell” rating to a “hold” rating in a research note on Tuesday, June 13th. Three equities research analysts have rated the stock with a sell rating and two have assigned a hold rating to the stock. The stock presently has a consensus rating of “Sell” and an average price target of $33.17.
In other Owens & Minor news, EVP Rony Camil Kordahi sold 2,231 shares of Owens & Minor stock in a transaction that occurred on Wednesday, May 24th. The shares were sold at an average price of $32.07, for a total transaction of $71,548.17. Following the transaction, the executive vice president now owns 27,555 shares of the company’s stock, valued at $883,688.85. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Erika T. Davis sold 9,317 shares of the business’s stock in a transaction on Tuesday, May 23rd. The stock was sold at an average price of $32.26, for a total transaction of $300,566.42. Following the completion of the transaction, the senior vice president now directly owns 63,979 shares in the company, valued at approximately $2,063,962.54. The disclosure for this sale can be found here. In the last three months, insiders sold 12,848 shares of company stock worth $413,962. 1.68% of the stock is currently owned by insiders.
Owens & Minor Company Profile
Owens & Minor, Inc is a healthcare services company that connects the world of medical products to the point of care. The Company provides supply chain assistance to the providers of healthcare services and the manufacturers of healthcare products, supplies and devices. The Company’s segments include Domestic, International and Clinical & Procedural Solutions (CPS).
Receive News & Ratings for Owens & Minor Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Owens & Minor Inc. and related companies with our FREE daily email newsletter.